z-logo
open-access-imgOpen Access
Ketamine and other Glutamate Receptor Modulating Agents for Treatment-Resistant Depression: A Systematic Review of Randomized Controlled Trials
Author(s) -
Ahmad Shamabadi,
Ali Ahmadzade,
Ali Aqamolaei,
Seyyed Hosein Mortazavi,
Alireza Hasanzadeh,
Shahin Akhondzadeh
Publication year - 2022
Publication title -
iranian journal of psychiatry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.503
H-Index - 17
eISSN - 2008-2215
pISSN - 1735-4587
DOI - 10.18502/ijps.v17i3.9733
Subject(s) - randomized controlled trial , medicine , ketamine , treatment resistant depression , cochrane library , amantadine , placebo , riluzole , memantine , pharmacology , meta analysis , depression (economics) , major depressive disorder , psychiatry , nmda receptor , glutamate receptor , alternative medicine , receptor , pathology , amygdala , economics , macroeconomics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom